Meet Dr. Johnson, Our CEO
Dr. Janice M. Johnson is an accomplished business performance, leadership, transformational change, and Lean Six Sigma Deployment expert with more than 20 years of experience. Dr. Johnson has led numerous cross-functional and international teams, and she has delivered cost savings, reduced cycle times, and improved productivity for small, medium, and large-sized companies, and across the United States, England, Germany, and Ireland.
Prior to becoming a business performance expert, Dr. Johnson enjoyed a highly successful career in the biotechnology industry where she developed IS CHO-CDTM, EX-CELL® NS0, and the JJ-series of proprietary reagents to increase the yield from biological processes for companies like Biomarin, Xoma, and Bayer. Dr. Johnson also led the development of GraphIti, a data capture, analysis, and reporting software that reduced Johnson & Johnson’s data analysis time in the pharmaceutical development department by 99%, and saved more than $1M annually.
A scholar-practitioner, Dr. Johnson is recognized for her innovation, strategic thinking, leadership, and outstanding performance. She is a subject matter expert on business performance in the private sector and in academia where she has served on numerous academic committees which include the Academy of Management, the Southern Management Association, and the School of Business Curriculum Council for the University of Phoenix.
Dr. Johnson earned a Ph.D. in Organization & Management from Capella University after completing research with Cummins Inc. to determine which leadership factors impacted the success of Lean Six Sigma deployments. Dr Johnson also earned M.S. and B.S. degrees in Biology from Louisiana Tech University where she studied biology, microbiology, chemistry, bioremediation, statistics, and environmental science.
Dr. Johnson is a certified Six Sigma Black Belt and a certified Lean Six Sigma Master Black Belt. In addition to leading the Johnson advantEDgeTM Institute, Dr. Johnson also serves as a Faculty member with international universities where she teaches graduate and undergraduate level courses in Operations Management, Leadership, Strategic Management, Logistics, Quantitative Research, Research Methods, and Healthcare Management.
Johnson, J.M. 2012. Steps to Complete a Lean Six Sigma Project. Johnson advantEDge Institute. Waxahachie, TX.
Johnson, J.M. (2009). Leadership and Organizational Performance in a Global, Fortune 500 Six Sigma Operating Company: A Correlational Research Study, Ph.D. dissertation, Capella University, Minneapolis, MN.
Johnson, J.M., Hartshorn, J., McNorton, S., Padilla, J.A., Mohabbat, T., Luo, S., & Etchberger, K. 2005. Process optimization for an NS0-derived hybridoma cell line in a chemically defined, protein-free medium. In F. Gòdia & M. Fussenegger (Eds.), Animal cell technology meets genomics (pp. 633-636). Netherlands: Springer.
Padilla, J.A., Burke V., Johnson, J., Hartshorn, J., McNorton, S., & Etchberger, K. 2005. Pretreatment with polycations enhances adenoviral infection levels in serum-free PER.C6TM cells as well as HEK 293 cells. In F. Gòdia & M. Fussenegger (Eds.), Animal cell technology meets genomics (pp. 281-283). Netherlands: Springer.
Tsao, M.C., Johnson, J.M., Bachelder, C., Wood, M.A., Boline, J.A., & Berzofsky, R.N.2000.Maintenance of high viability during direct transition of CHO-K1 cell growth from 10% to 0% serum:No adaptation required. In A. Bernard, B. Griffiths, N. Noé, & F. Wurm (Eds.), Animal cell technology: Products from cells, cells as products(pp 103-106). Netherlands: Springer.